Mark Hurwitz
Papers
1
Total Citations
8
H-Index
1
About
Mark Hurwitz is a leading figure in radiation oncology, whose research has fundamentally shaped the modern treatment of prostate cancer. His work centers on the comparative effectiveness of advanced radiation technologies, particularly the nuanced debate between high-dose rate brachytherapy (HDR-BT) and stereotactic body radiation therapy (SBRT) delivered via robotic arm systems like CyberKnife. In his highly cited 2014 study, Hurwitz conducted a rigorous analysis of published data to evaluate whether robotic arm SBRT could truly be considered a "virtual high-dose rate brachytherapy." By systematically comparing the clinical outcomes and dosimetric advantages of these emerging modalities, he provided critical evidence that helped clinicians understand their relative strengths and limitations. This work, which has garnered significant attention with 8 citations, is a cornerstone for physicians navigating the choice between these popular, non-invasive treatments. Hurwitz’s contributions have been instrumental in moving the field toward more personalized, evidence-based decision-making, ensuring that patients receive the most effective therapy for their specific disease characteristics.
Research Focus
Key Achievements
Top Papers
- 1